Breaking News Instant updates and real-time market news.

AMPH

Amphastar

$17.21

-0.74 (-4.12%)

10:41
08/09/18
08/09
10:41
08/09/18
10:41

Amphastar shares 'about the future,' says Wells Fargo

Wells Fargo analyst David Maris noted that Amphastar reported Q2 revenues that topped his estimate, but adjusted EPS that missed his and the consensus view. However, he does not view the miss as meaningful, as the lower than expected EPS was mainly due to spending on the pipeline and he believes Amphastar "shares are not about the current, but about the future." Maris, who thinks Amphastar could become a "much larger company" depending on key approvals over the next several years, keeps an Outperform rating on the shares with a price target of $26.

AMPH Amphastar
$17.21

-0.74 (-4.12%)

07/20/18
WELS
07/20/18
NO CHANGE
Target $23
WELS
Outperform
Wells Fargo positive on Amphastar after review of new Drug Master Files
Wells Fargo analyst David Maris says his review of new Drug Master Files added to the FDA's database in Q2 indicates that Amphastar Nanjing Pharmaceuticals (AMPH) filed a DMF for insulin aspart, the active ingredient in Novo Nordisk's (NVO) blockbuster diabetes therapy NovoLog. The NovoLog franchise had U.S. sales of $6.7B in 2017 while the original NovoLog product totaled $2.4B, Maris tells investors in a research note titled "DMF Dig Warrants Excitement." Amphastar confirmed the DMF filing to Maris and said it relates to the finished product pipeline, but would not comment on what specific branded product the filing targets. The insulin aspart DMF filing is from Amphastar's facility in Nanjing, China, which indicates this facility, not the company's plant in France, will be working on the NovoLog generic, Maris writes. The analyst likes Amphastar's focus on "difficult to develop generics and selected brands" and thinks the company as the potential to post "excellent growth" over a multiyear period. Maris keeps an Outperform rating on the shares with a $23 price target
06/19/18
WELS
06/19/18
NO CHANGE
WELS
Outperform
Amphastar generic Isuprel has $10M-$25M sales potential, says Wells Fargo
After Amphastar (AMPH) announced that the FDA approved its therapeutically equivalent generic of Valeant's (VRX) Isuprel, Wells Fargo analyst David Maris said he will discuss this with management when he meets them later today but his preliminary estimate is that this generic has a sales opportunity of $10M-$25M. Maris has an Outperform rating on Amphastar shares.
03/21/18
WELS
03/21/18
NO CHANGE
WELS
Outperform
Amphastar court win a 'major' positive, says Wells Fargo
Wells Fargo analyst David Maris called the news of Massachusetts' District Court entering a final judgement in favor of Amphastar (AMPH) in the patent lawsuit regarding Lovenox brought by Momenta (MNTA) and Novartis' (NVS) Sandoz division a "major positive" that again demonstrates Amphastar's ability to face down larger, better-funded companies and get difficult products to market. He maintains an Outperform rating on Amphastar shares.
03/13/18
BMOC
03/13/18
NO CHANGE
Target $19
BMOC
Market Perform
Amphastar demonstrating solid execution, says BMO Capital
BMO Capital analyst Gary Nachman raised his price target on Amphastar to $19 from $17 after the company's Q4 earnings. Nachman says the gross margin pressure has been offset by lower spending, while the tax reform benefits drove an earnings beat. The analyst adds that while the company has recently demonstrated "solid execution" in securing approvals for its generic injectables pipeline, more meaningful ANDA will be needed to achieve this year's consensus. Nachman keeps his Market Perform rating on Amphastar.

TODAY'S FREE FLY STORIES

PIR

Pier 1 Imports

$1.80

0.045 (2.56%)

17:46
09/20/18
09/20
17:46
09/20/18
17:46
Recommendations
Pier 1 Imports analyst commentary  »

Pier 1 Imports price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$46.06

1.01 (2.24%)

17:43
09/20/18
09/20
17:43
09/20/18
17:43
Hot Stocks
Breaking Hot Stocks news story on Micron »

Micron reverses, now down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

ACXM

Acxiom

$50.28

2.09 (4.34%)

, IPG

Interpublic Group

$22.68

0.315 (1.41%)

17:41
09/20/18
09/20
17:41
09/20/18
17:41
Hot Stocks
Acxiom shareholders approve AMS sale, will switch name to LiveRamp after close »

Acxiom (ACXM) announced…

ACXM

Acxiom

$50.28

2.09 (4.34%)

IPG

Interpublic Group

$22.68

0.315 (1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

IPCI

Intellipharmaceutics

$2.92

0.15 (5.42%)

17:39
09/20/18
09/20
17:39
09/20/18
17:39
Syndicate
Breaking Syndicate news story on Intellipharmaceutics »

Intellipharmaceutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$301.53

-10.71 (-3.43%)

17:30
09/20/18
09/20
17:30
09/20/18
17:30
Hot Stocks
Northrop Grumman completes first qualification test of rocket motor in Atlas V »

Northrop Grumman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YUM

Yum! Brands

$88.96

0.39 (0.44%)

17:28
09/20/18
09/20
17:28
09/20/18
17:28
Recommendations
Yum! Brands analyst commentary  »

Yum! Brands continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

17:25
09/20/18
09/20
17:25
09/20/18
17:25
Conference/Events
SEC to hold an investor roundtable »

Investor Roundtable to…

FSCT

ForeScout

$39.56

1.2 (3.13%)

17:24
09/20/18
09/20
17:24
09/20/18
17:24
Hot Stocks
ForeScout beneficial owner Amadeus Capital Partners sells $4.6M in shares »

ForeScout beneficial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

MU

Micron

$46.06

1.01 (2.24%)

17:23
09/20/18
09/20
17:23
09/20/18
17:23
Hot Stocks
Micron says it is seeing CPU shortage »

Says confident of long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

CWK

Cushman & Wakefield

$18.00

0.37 (2.10%)

17:21
09/20/18
09/20
17:21
09/20/18
17:21
Hot Stocks
Cushman & Wakefield arranges $55M sale of a Whole Foods property »

A 50,451-square-foot…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACAD

Acadia

$19.08

3.97 (26.27%)

17:17
09/20/18
09/20
17:17
09/20/18
17:17
Hot Stocks
Acadia issues states affirming positive risk profile of NUPLAZID »

ACADIA Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

UNFI

United Natural Foods

$33.83

0.54 (1.62%)

17:16
09/20/18
09/20
17:16
09/20/18
17:16
Hot Stocks
United Natural Foods plunges after Q4 margins fall to 14.5% »

Shares of United Natural…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 28

    Oct

MDXG

MiMedx

$6.18

0.68 (12.36%)

17:15
09/20/18
09/20
17:15
09/20/18
17:15
Hot Stocks
MiMedx announces Nasdaq listing extension »

MiMedx Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

MDXG

MiMedx

$6.18

0.68 (12.36%)

17:15
09/20/18
09/20
17:15
09/20/18
17:15
Hot Stocks
MiMedx: Previous executive separations to be treated as termination 'for cause' »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

UTX

United Technologies

$141.91

1.41 (1.00%)

17:11
09/20/18
09/20
17:11
09/20/18
17:11
Hot Stocks
United Technologies awarded $2.46B Department of Defense contract modification »

United Technologies has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEXA

Nexa Resources

$11.89

0.1 (0.85%)

17:10
09/20/18
09/20
17:10
09/20/18
17:10
Hot Stocks
Nexa Resources authorizes $30M share buyback program »

Nexa Resources has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AT

Atlantic Power

$2.15

-0.025 (-1.15%)

17:06
09/20/18
09/20
17:06
09/20/18
17:06
Hot Stocks
Atlantic Power to acquire two biomass plants in South Carolina for $13M »

Atlantic Power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$20.00

0.4 (2.04%)

17:05
09/20/18
09/20
17:05
09/20/18
17:05
Hot Stocks
Vanda Pharmaceuticals announces HETLIOZ patent listing in FDA Orange Book »

Vanda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

WRD

WildHorse Resource

$21.31

-0.12 (-0.56%)

17:05
09/20/18
09/20
17:05
09/20/18
17:05
Hot Stocks
WildHorse Resource adds acreage in Burleson, Brazos, Lee, Washington Counties »

WildHorse Resource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

, RDS.B

Royal Dutch Shell

$68.85

0.56 (0.82%)

17:02
09/20/18
09/20
17:02
09/20/18
17:02
Periodicals
Shell in discussions to sell $1.3B in Gulf Coast assets, Bloomberg says »

Royal Dutch Shell (RDS.A)…

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

RDS.B

Royal Dutch Shell

$68.85

0.56 (0.82%)

APC

Anadarko

$63.86

-0.88 (-1.36%)

EQNR

Equinor

$26.45

-0.09 (-0.34%)

CVX

Chevron

$119.46

-0.04 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

  • 26

    Sep

MU

Micron

$46.06

1.01 (2.24%)

17:02
09/20/18
09/20
17:02
09/20/18
17:02
Earnings
Micron sees Q1 EPS $2.95, +/- 7c, consensus $2.73 »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

AL

Air Lease

$45.80

0.09 (0.20%)

, EADSY

Airbus

$0.00

(0.00%)

17:02
09/20/18
09/20
17:02
09/20/18
17:02
Hot Stocks
Air Lease announces delivery of Airbus A320-200neo aircraft with SKY »

Air Lease (AL) announced…

AL

Air Lease

$45.80

0.09 (0.20%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

MU

Micron

$46.06

1.01 (2.24%)

16:52
09/20/18
09/20
16:52
09/20/18
16:52
Hot Stocks
Micron says it achieved record revenue in FY18 »

Says expects 1ynm sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

PMBC

Pacific Mercantile Bancorp

$9.75

0.025 (0.26%)

16:50
09/20/18
09/20
16:50
09/20/18
16:50
Hot Stocks
Breaking Hot Stocks news story on Pacific Mercantile Bancorp »

EJF Capital reports 7.3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

MU

Micron

$46.06

1.01 (2.24%)

16:46
09/20/18
09/20
16:46
09/20/18
16:46
Hot Stocks
Breaking Hot Stocks news story on Micron »

Micron up 5.7% to $48.69…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.